Efficacy of Gemcitabine Plus Nab-Paclitaxel in Second-Line Treatment of Metastatic Pancreatic Cancer
| dc.authorwosid | Aykan, Musa Barış/Aek-4253-2022 | |
| dc.authorwosid | Araz, Murat/C-6388-2015 | |
| dc.contributor.author | Sezgin, Y. | |
| dc.contributor.author | Karhan, O. | |
| dc.contributor.author | Urakci, Z. | |
| dc.contributor.author | Mecidova, N. | |
| dc.contributor.author | Araz, M. | |
| dc.contributor.author | Sakin, A. | |
| dc.contributor.author | Ergun, Y. | |
| dc.date.accessioned | 2025-05-10T17:25:32Z | |
| dc.date.available | 2025-05-10T17:25:32Z | |
| dc.date.issued | 2024 | |
| dc.department | T.C. Van Yüzüncü Yıl Üniversitesi | en_US |
| dc.department-temp | [Sezgin, Y.] Yuzuncu Yil Univ, Med Oncol, Van, Turkiye; [Karhan, O.; Urakci, Z.] Dicle Univ, Med Oncol Dept, Diyarbakir, Turkiye; [Mecidova, N.] Marmara Univ Pendik Training & Res State Hosp, Med Oncol, Istanbul, Turkiye; [Araz, M.] Necmettin Erbakan Univ, Med Oncol, Meram Med Fac, Konya, Turkiye; [Sakin, A.] Okmeydani Training & Res Hosp, Med Oncol Dept, Istanbul, Turkiye; [Ercek, B. M.] Van Yuzuncu Yil Univ, Med Oncol Dept, Van, Turkiye; [Urun, M.] Ankara Univ, Med Oncol, Med Sch, Cebeci Hastaneleri Tibbi Onkol, Ankara, Turkiye; [Urvay, S.] Acibadem Kayseri Hosp, Med Oncol Dept, Kayseri, Turkiye; [Aykan, M. B.] Gulhane Training & Reseach Hosp, Med Oncol Dept, Ankara, Turkiye; [Kocak, S.] Istanbul Univ, Med Oncol, Cerrahpasa Fac Med, Istanbul, Turkiye; [Arici, M. O.] Antalya Training & Res Hosp, Med Oncol Dept, Antalya, Turkiye; [Avci, N.] Balikesir Univ, Med Oncol Dept, Balikesir, Turkiye; [Alkan, A.] Mugla Sitki Kocman Univ, Med Oncol Dept, Fac Med, Mugla, Turkiye; [Ozcelik, M.] Univ Hlth Sci, Med Oncol Dept, Istanbul, Turkiye; [Aldemir, M. N.] Ataturk Univ, Med Oncol Dept, Med Fac, Erzurum, Turkiye; [Ergun, Y.] Antalya City Hosp, Med Oncol Dept, Antalya, Turkiye | en_US |
| dc.description.woscitationindex | Science Citation Index Expanded - Conference Proceedings Citation Index - Science | |
| dc.identifier.doi | 10.1016/j.annonc.2024.08.1586 | |
| dc.identifier.endpage | S930 | en_US |
| dc.identifier.issn | 0923-7534 | |
| dc.identifier.issn | 1569-8041 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | S930 | en_US |
| dc.identifier.uri | https://doi.org/10.1016/j.annonc.2024.08.1586 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14720/11402 | |
| dc.identifier.volume | 35 | en_US |
| dc.identifier.wos | WOS:001326612902145 | |
| dc.identifier.wosquality | Q1 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier | en_US |
| dc.relation.ispartof | Annual Congress of the European-Society-for-Medical-Oncology (ESMO) -- SEP 13-17, 2024 -- Barcelona, SPAIN | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Efficacy of Gemcitabine Plus Nab-Paclitaxel in Second-Line Treatment of Metastatic Pancreatic Cancer | en_US |
| dc.type | Conference Object | en_US |